Latest S2Medical News & Updates

See the latest news and media coverage for S2Medical. We track all announcements, press releases, and industry mentions in real time, all in one place.

S2Medical

Medical technology company developing wound-healing and antimicrobial peptide treatments

s2m.se

Headquarters: Linköping, Sweden
Founded year: 2013
Company type: Public company
Number of employees: 13–50
Industry: Biotechnology & Medical Research

Last updated September 26

Latest news about S2Medical

In short: S2Medical raised 2.9 MSEK in oversubscribed rights issue, posted positive H1 result and validated European patent.

Company announcements

August 26 S2Medical

S2Medical announces a rights issue for investors

The subscription period runs from August 24 to September 10, 2026, with detailed instructions available on the company website.

August 21 S2Medical

S2Medical reports revenue growth and positive operating result in the first half of 2026

Revenue rose to SEK 7.4 million and the operating result turned positive. The company conducted new share issues and validated a European patent.

June 12 S2Medical

S2Medical holds annual general meeting and decides on new issues

The board was re-elected, the articles of association were amended. A directed issue to SilverSkog Group and a rights issue were decided.

June 11 S2Medical

S2Medical sets subscription price in directed issue

The subscription price is SEK 0.0055 per A-share according to VWAP during the period May 15–June 11, 2026.

Media coverage

September 26 Marketscreener

20/02 S2Medical H2 net sales amount to 7.5 mln SEK RE

21-02-25 S2Medical AB (publ) reports results for the full year ended December 31, 2024 CI 23-08-24 S2Medical AB (publ) reports results for the...

September 2 MarketScreener

Valuation S2Medical AB Deutsche Boerse AG

May. 13 S2Medical plans rights issue to raise SEK 2.9 mln RE ...

August 21 Zone Bourse

S2Medical AB (publ) publishes its results for the half-year ended June 30, 2026

S2Medical AB has published its financial results for the half-year ended June 30, 2026. For this half-year, the company recorded revenue...

February 12, 2019 Dagens industri

S2Medical on its way to First North

The investment company's portfolio company S2Medical, which develops and sells wound healing products, is on its way to Nasdaq First North and will in connection with that carry out a...

Never miss news about S2Medical

Track S2Medical and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

S2Medical competitors & trending companies

Browse news for competitors to S2Medical and other trending companies.